fda compounding semaglutide enforcement news november 2025 Beyond the Headlines: Warning Letters to GLP-1 Compounders Compounded weight loss injections —

peptides will be administered during weekly in-office appointments to allow for close monitoring during the initiation of the medication

Jays RETA 15MG in laboratory tests

Remedium Retatrutide 30mg Pen Key Features 30mg Retatrutide per prefilled pen Triple-agonist metabolic research compound Precision dosing delivery system Manufactured under controlled laboratory conditions Designed for advanced research and investigational use How It Works Retatrutide targets GLP-1, GIP, and glucagon receptors , working synergistically to regulate appetite signals, enhance metabolic output, and influence energy balance

It's a common but often overlooked result of losing a vast amount of weight that can be devastating, medically and emotionally